Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About MCB
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Molecular and Cellular Biology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About MCB
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Articles

Knockdown of ALR (MLL2) Reveals ALR Target Genes and Leads to Alterations in Cell Adhesion and Growth

Irina Issaeva, Yulia Zonis, Tanya Rozovskaia, Kira Orlovsky, Carlo M. Croce, Tatsuya Nakamura, Alex Mazo, Lea Eisenbach, Eli Canaani
Irina Issaeva
1Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 76100, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yulia Zonis
1Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 76100, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tanya Rozovskaia
1Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 76100, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kira Orlovsky
1Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 76100, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carlo M. Croce
2Institute of Genetics and Comprehensive Cancer Center, Ohio State University, Columbus, Ohio 43221
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tatsuya Nakamura
2Institute of Genetics and Comprehensive Cancer Center, Ohio State University, Columbus, Ohio 43221
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alex Mazo
3Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania 19107
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lea Eisenbach
4Department of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eli Canaani
1Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 76100, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: eli.canaani@weizmann.ac.il
DOI: 10.1128/MCB.01506-06
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Additional Files
  • FIG. 1.
    • Open in new tab
    • Download powerpoint
    FIG. 1.

    Purification of the ALR complex and identification of ALR-associated proteins. (A) Scheme for four-step purification of the ALR complex. IAC, immunoaffinity column. (B) Coomassie staining of proteins eluted from anti-ALR, anti-PTIP, anti-UTX, and control immunoaffinity columns. About 50 μg of affinity-purified complex was eluted from each IAC (except for the control column); 98% of this amount was used for Coomassie staining and subsequent mass spectrometry analysis. For comparison of protein pattern complexities before, during, and after complex purification, Coomassie staining patterns of 50 μg of crude K562 nuclear extract (lane 1) and 50 μg of the ALR-enriched Superose 6 pooled fractions (lane 2) are shown, corresponding to 1/6,000 and 1/60, respectively, of the total material used for complex purification and subjected to IAC. The positions of molecular mass markers are indicated on the left. *, components of SET1-like histone methyltransferase complexes. (C) The identities of ALR complex components were verified by immunoblotting.

  • FIG. 2.
    • Open in new tab
    • Download powerpoint
    FIG. 2.

    Confirmation of ALR complex composition. (A) Size fractionation of the enriched ALR complex. The ALR-enriched K562 nuclear extracts, obtained from subsequent purification steps on P11 and Q-Sepharose columns, were applied to a preparative Superose 6 column. One percent of each fraction collected from Superose 6 was analyzed by immunoblotting using Abs directed to various ALR complex components. fr#, fraction number. The positions of molecular mass markers determined in a parallel run are indicated at the top. (B) Coprecipitation of ALR with other ALR complex components from A549 cells. Crude nuclear extracts obtained from A549 cells were utilized in reciprocal coimmunoprecipitations. Proteins coprecipitated (IP) with anti-ALR, anti-PTIP, anti-UTX, and anti-RBQ3 Abs, as well as with control IgG, were separated on SDS-PAGE and immunoblotted (IB) with the indicated Abs. Since different amounts of Abs were used in some IPs, the analysis is qualitative rather than quantitative.

  • FIG. 3.
    • Open in new tab
    • Download powerpoint
    FIG. 3.

    Histone methyltransferase activities of the ALR complex and of the ALR SET domain. (A) The ALR complex methylates histone H3. Anti-ALR, anti-PTIP, anti-UTX, or control immunoprecipitate (IP) was incubated with core histones and the methyl donor H3-SAM. Samples were resolved on 15% SDS-PAGE, stained with Coomassie blue (right), amplified, dried, and fluorographed (left). Histone subunits are indicated on the right. (B) ALR SET domain methylates H3K4. Two ALR SET domain-containing fragments, encompassing the ALR amino acids 5009 to 5261 and 5089 to 5261 (designated SET a and SET b, respectively), were fused to GST and overexpressed in 293T cells. Cells overexpressing GST only were used as a control. The overexpressed polypeptides were immunoprecipitated from cell lysates using anti-GST Ab and incubated with N-terminal H3 peptides containing unmodified K4 and K9, dimethylated K4, dimethylated K9, or trimethylated K9. Samples were resolved on 20% SDS-PAGE, stained with Coomassie blue (bottom), and fluorographed (top). (C) The recombinant ALR SET domain does not interact with the ASH2, RBQ3, and WDR5 proteins. GST-SET fusions or control GST was precipitated from 293T cell lysates with anti-GST Ab and analyzed by immunoblotting using anti-GST, -ASH2, -RBQ3, or -WDR5 Abs. Five percent of each GST-SET- or control GST-overexpressing lysate was loaded as an input control. (D) The ALR complex methylates H3 peptides containing either unmodified or dimethylated K4. Anti-ALR, anti-PTIP, anti-UTX, or control immunoprecipitate was incubated with unmodified or appropriately methylated H3 peptides. The reaction was analyzed as described above.

  • FIG. 4.
    • Open in new tab
    • Download powerpoint
    FIG. 4.

    (A) Effects of ALR shRNAs on the level of ALR. Four stable cell lines generated by infection of HeLa cells with retroviruses carrying four different ALR shRNA constructs (lanes shALR SP1 to shALR A10) and two control HeLa cell lines, infected with the retroviral vector or with noncompetent ALR shRNA D, were examined by immunoblotting for expression of the ALR protein and some ALR complex components. (B) Confirmation of the microarray results by RT-PCR analysis. RNAs isolated from the above-described cell lines were used for semiquantitative RT-PCR analysis to monitor the expression of selected genes. PCR cycle numbers were individually optimized for each gene so that each reaction fell into the linear range of product amplification. The genes analyzed included 11 downregulated genes (CSPG4, CRIP1, CRIP2, DKK1, FABP3, ENO3, LOXL1, NT5E, GPR56, LAMB3, and MEOX1), 1 upregulated gene (DPT), and 2 control genes (β-actin and HoxA9).

  • FIG. 5.
    • Open in new tab
    • Download powerpoint
    FIG. 5.

    ChIP analysis of CRIP2 (A), ENO3 (B), CSPG4 (C), DKK1 (D), and HoxA9 (E) loci in vector-infected and SP3 cells. The presence of the ALR, PTIP, and UTX proteins, as well as of histone H3K4 trimethylation, on several regions of CRIP2, ENO3, CSPG4, and DKK1 loci and on the 5′ end of the HoxA9 locus was examined. Chromatin was prepared from the control vector-infected cells and from the ALR-deprived SP3 cell line. The analyzed portions of the genes are depicted to the right of panels A to D and at the bottom of panel E. The boxes shown on the schemes indicate the first exons, and the dark areas correspond to the coding regions. The arrows point to the transcription initiation sites; a to e correspond to the sequences amplified by PCR following immunoprecipitation with each of the six Abs (two anti-ALR Abs, anti-PTIP, anti-UTX, control IgG, and anti-trimethylated H3K4). For input, 0.1% or 0.5% of the amount of sonicated chromatin to be subsequently processed for ChIP was removed and PCR amplified.

  • FIG. 6.
    • Open in new tab
    • Download powerpoint
    FIG. 6.

    Changes in the morphology of ALR knockdown cells during spreading. (A and B) Differences in dynamics and modes of cell spreading. (A) Control (Vector) and ALR-deficient (SP3) cells were plated on fibronectin-coated dishes and analyzed by time-lapse photography during the subsequent 4 h. The numbers represent the time after plating in min. (B) Two control (Vector and D) and two ALR-underexpressing (SP3 and A10) cell lines were seeded on fibronectin-coated coverslips and fixed with 3.7% paraformaldehyde at different time points during the subsequent 15 h. Typical photographs of the cells at 6 and 15 h after being plated are shown. (C and D) Decreased numbers of FA and alterations in actin cytoskeleton organization in spreading ALR-deficient cells. (C) Control (Vector) and ALR knockdown (SP3) cells were processed as described for panel B, and FA were double stained with anti-vinculin and anti-paxillin Abs. The numbers of FA formed by each cell type at the indicated time points were calculated. The data represent the average FA number of 30 cells plus standard deviation. (D) The cells described above, fixed at 3 h after being plated, were stained for filamentous actin with tetramethyl rhodamine isothiocyanate-phalloidin (red) and for FA with anti-paxillin Ab (green). Bars (A, B, and D), 50 μm.

  • FIG. 7.
    • Open in new tab
    • Download powerpoint
    FIG. 7.

    ALR knockdown affects cell growth, apoptosis, and migration. (A) Cell growth assay. The growth rates of three ALR-deprived HeLa cell lines (SP3, SP4, and A10) and of the control cells (Vector and D) were determined by plating 105 cells in triplicate on six-well plates and counting the cells every 24 h during the subsequent 4 days. The error bars represent the standard deviations of three independent experiments. (B) Increased apoptosis in the ALR-deprived cells. Control (Vector and D) and ALR-deprived (SP1, SP3, SP4, and A10) HeLa cells were stained with the TUNEL assay kit. Percentages of TUNEL-positive (apoptotic) populations are shown. The error bars represent the standard deviations of three independent experiments. (C) ALR knockdown inhibits soft-agar growth of HeLa cells. Five hundred and 1,000 cells/3-cm dish were seeded on 0.3% agar in triplicate. Three weeks later, the dishes were photographed and the colonies were counted. The experiment was repeated twice. Typical photographs of plates seeded with control (Vector) and ALR-deficient (SP3) cells are shown on the left. The histogram shows the numbers of colonies formed in each cell line at both plating concentrations as a percentage of the control vector-expressing cells. Absolute colony numbers are shown above the bars. (D) Effect of ALR knockdown on cell migration. A scratch injury was introduced with a micropipette tip into confluent cultures of the control (Vector) and ALR-depleted (SP3) A549 cells. Phase-contrast images of cultures were taken either immediately after scratching (0 h) or 16 h later.

  • FIG. 8.
    • Open in new tab
    • Download powerpoint
    FIG. 8.

    Decreased tumorigenicity of ALR knockdown cells in nude mice. (A) Ten animals in each group were injected subcutaneously with 106 cells of either control (Vector and D) or ALR-deficient (SP3 and A10) HeLa cell lines. Tumor volumes were determined at regular time intervals. The experiment was stopped after 4 weeks, when the tumors in the control groups reached 1 to 1.5 cm in diameter. The results represent the means ± standard errors (SE). (B) Photographs and (C) mean weights of tumors formed in each group at 4 weeks after injection. Error bars, SE.

Tables

  • Figures
  • Additional Files
  • TABLE 1.

    The 20 genes most strongly downregulated in SP3 cellsa

    GenBank accession no.Gene product symbol and nameChange (fold)bFunction, biological process
    U36190 CRIP2, cysteine-rich protein 2−25.9 ± 4.8Unknown
    NM_005576 LOXL1, lysyl oxidase-like 1−22.6 ± 2.4Formation and repair of extracellular matrix, aging
    X96753 CSPG4/MCSP, chondroitin-sulfate proteoglycan 4 (melanoma associated)−21.3 ± 2.3Cell polarization, spreading, motility and proliferation, tumor invasion
    AL554008 GPR56, G protein-coupled receptor 56−19.1 ± 2.7Cell adhesion, cell-cell signaling, brain development
    NM_002526 NT5E, 5′-nucleotidase, ecto (CD73)−17.6 ± 3.5Nucleotide metabolism
    L25541 LAMB3, laminin beta-3 chain−17.6 ± 5.1Extracellular matrix component; cell adhesion, epidermis development
    NM_001976 ENO3, enolase 3 (beta)−17.2 ± 0.6Glycolisis, muscle development and regeneration
    NM_012242 DKK1, Dickkopf (Xenopus) homolog 1−16.9 ± 3.1Signal transducer; development (extracellular Wnt receptor signaling antagonist)
    X56549 FABP3, fatty acid binding protein 3−15.0 ± 2.3Lipid transporter; regulation of cell proliferation
    NM_004527 MEOX 1, mesenchyme homeobox 1−12.7 ± 2.5Transcription factor; development (mesoderm induction and regional specification)
    NM_001311 Cystine-rich protein 1 (intestinal)−11.6 ± 2.9Cell proliferation, antimicrobial humoral response
    NM_005756 GPR64, G protein-coupled receptor 64−11.3 ± 3.0Neuropeptide signaling pathway, spermatogenesis
    AF020769 TNNC1, troponin C type 1 (cardiac)−9.4 ± 1.8Regulation of muscle contraction, muscle development
    X79857 TNNT2, troponin T type 2−9.1 ± 2.5Regulation of muscle contraction, muscle development
    NM_000638 VTN, vitronectin (serum spreading factor, complement S protein)−9.1 ± 2.0Cell adhesion, spreading, immune response
    NM_002589 PCDH7, BH-protocadherin (brain, heart)−7.7 ± 1.3Homophilic cell adhesion, regulation of neuronal connections
    NM_000908 NPR3, natriuretic peptide receptor C, guanylate cyclase C−6.9 ± 1.7Skeletal development
    M64930 PPP2R2B, protein phosphatase 2, regulatory subunit B (PR 52), beta isoform−5.9 ± 1.7Signal transduction
    NM_005585 MADH6, MAD (mother against decapentapledgic) Drosophila homolog 6, SMAD6−5.5 ± 2.2Intracellular antagonist of transforming growth factor β/BMP receptor signaling, regulation of transcription
    NM_001449 FHL1, four and a half LIM domains 1 protein−5.0 ± 1.9Muscle development and differentiation, cell adhesion (effector of integrin signaling), cell growth
    • ↵ a Not including ESTs. Two genes overexpressed in SP3 cells are those encoding DPT, dermatopontin (accession number NM_001937 ), and ABCA5, ATP-binding cassette, subfamily A (ABC1), member 5 (accession number AY028897 ), giving 8.00- ± 3.57- and 3.20- ± 1.12-fold change, respectively.

    • ↵ b Mean ± SE of three independent experiments.

Additional Files

  • Figures
  • Tables
  • Supplemental material

    Files in this Data Supplement:

    • Supplemental file 1 - Supplemental text
      PDF document, 146 KB.
    • Supplemental file 2 - Fig. S1 (Expression level of ALR), S2 (Cell cycle profiles of control and ALR-deprived cells), S3 (Colony growth of cells with ALR knockdown), S4 and S5 (PTIP but not ALR localizes to irradiation-induced DNA damage sites [S4] and forms nuclear foci in S phase [S5]), and S6 (Differences in patterns of fractionation of PTIP and ALR on P11 phosphocellulose)
      PDF document, 497 KB.
    • Supplemental file 3 - Table S1 (Genes downregulated in SP3 cells)
      PDF document, 84 KB.
PreviousNext
Back to top
Download PDF
Citation Tools
Knockdown of ALR (MLL2) Reveals ALR Target Genes and Leads to Alterations in Cell Adhesion and Growth
Irina Issaeva, Yulia Zonis, Tanya Rozovskaia, Kira Orlovsky, Carlo M. Croce, Tatsuya Nakamura, Alex Mazo, Lea Eisenbach, Eli Canaani
Molecular and Cellular Biology Feb 2007, 27 (5) 1889-1903; DOI: 10.1128/MCB.01506-06

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Molecular and Cellular Biology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Knockdown of ALR (MLL2) Reveals ALR Target Genes and Leads to Alterations in Cell Adhesion and Growth
(Your Name) has forwarded a page to you from Molecular and Cellular Biology
(Your Name) thought you would be interested in this article in Molecular and Cellular Biology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Knockdown of ALR (MLL2) Reveals ALR Target Genes and Leads to Alterations in Cell Adhesion and Growth
Irina Issaeva, Yulia Zonis, Tanya Rozovskaia, Kira Orlovsky, Carlo M. Croce, Tatsuya Nakamura, Alex Mazo, Lea Eisenbach, Eli Canaani
Molecular and Cellular Biology Feb 2007, 27 (5) 1889-1903; DOI: 10.1128/MCB.01506-06
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

cell proliferation
DNA-Binding Proteins
Neoplasm Proteins

Related Articles

Cited By...

About

  • About MCB
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #MCBJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0270-7306; Online ISSN: 1098-5549